MDT

96.13

-0.07%↓

A

143.79

-2.29%↓

VEEV

227.66

-3.26%↓

HQY

83.45

-2.26%↓

PHR.US

16.38

-3.99%↓

MDT

96.13

-0.07%↓

A

143.79

-2.29%↓

VEEV

227.66

-3.26%↓

HQY

83.45

-2.26%↓

PHR.US

16.38

-3.99%↓

MDT

96.13

-0.07%↓

A

143.79

-2.29%↓

VEEV

227.66

-3.26%↓

HQY

83.45

-2.26%↓

PHR.US

16.38

-3.99%↓

MDT

96.13

-0.07%↓

A

143.79

-2.29%↓

VEEV

227.66

-3.26%↓

HQY

83.45

-2.26%↓

PHR.US

16.38

-3.99%↓

MDT

96.13

-0.07%↓

A

143.79

-2.29%↓

VEEV

227.66

-3.26%↓

HQY

83.45

-2.26%↓

PHR.US

16.38

-3.99%↓

Search

Smith & Nephew PLC ADR

Открыт

32.21 -4.34

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

31.96

Макс.

33.78

Ключевые показатели

By Trading Economics

Доход

296M

Продажи

3B

P/E

Средняя по отрасли

29.768

87.826

Дивидендная доходность

2.29

Рентабельность продаж

9.895

Сотрудники

17,000

EBITDA

723M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+4.65% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.29%

2.26%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

14B

Предыдущая цена открытия

36.55

Предыдущая цена закрытия

32.21

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Smith & Nephew PLC ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

12 янв. 2026 г., 23:54 UTC

Обсуждения рынка

CBA Could Underperform Again in 2026 -- Market Talk

12 янв. 2026 г., 23:48 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

12 янв. 2026 г., 23:48 UTC

Обсуждения рынка

Nikkei May Rise on Weaker Yen -- Market Talk

12 янв. 2026 г., 23:43 UTC

Обсуждения рынка

Gold Edges Lower on Likely Technical Correction -- Market Talk

12 янв. 2026 г., 23:18 UTC

Приобретения, слияния, поглощения

Paramount Sues Warner Bros., Plans Proxy Fight. The Ellisons Aren't Giving Up. -- Barrons.com

12 янв. 2026 г., 21:56 UTC

Обсуждения рынка

Light & Wonder Gets Positive Outcome From Lawsuit -- Market Talk

12 янв. 2026 г., 21:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

12 янв. 2026 г., 21:50 UTC

Обсуждения рынка

Health Care Roundup: Market Talk

12 янв. 2026 г., 21:50 UTC

Обсуждения рынка
Отчет

Auto & Transport Roundup: Market Talk

12 янв. 2026 г., 21:18 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

12 янв. 2026 г., 21:18 UTC

Обсуждения рынка

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

12 янв. 2026 г., 20:54 UTC

Отчет

Gap, Fortinet, and More Stocks That Usually Outperform After Earnings -- Barrons.com

12 янв. 2026 г., 20:48 UTC

Обсуждения рынка

Oil Futures Settle Higher in Choppy Trade -- Market Talk

12 янв. 2026 г., 20:33 UTC

Обсуждения рынка

U.S. Natural Gas Jumps on Colder Weather Outlook -- Market Talk

12 янв. 2026 г., 20:18 UTC

Приобретения, слияния, поглощения

Credit Agricole Sees Banco BPM Stake Helping 2025 Net by EUR200M >ACA.FR

12 янв. 2026 г., 20:18 UTC

Приобретения, слияния, поглощения

Credit Agricole: European Central Bank Approves Crossing of 20% Threshold in Share Capital of Banco BPM

12 янв. 2026 г., 19:39 UTC

Обсуждения рынка

J&J CEO: Trump Pact Allows Company to Focus on Core Operations -- Market Talk

12 янв. 2026 г., 19:36 UTC

Обсуждения рынка

Gold and Silver Set New Records on Fed Probe -- Market Talk

12 янв. 2026 г., 19:36 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

12 янв. 2026 г., 19:33 UTC

Обсуждения рынка

Venezuela's 'Proven' Oil Reserves Raises Questions -- Market Talk

12 янв. 2026 г., 19:24 UTC

Приобретения, слияния, поглощения

Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23

12 янв. 2026 г., 19:22 UTC

Приобретения, слияния, поглощения

Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'

12 янв. 2026 г., 18:21 UTC

Приобретения, слияния, поглощения

Paramount Plans Proxy Fight to Push Hostile Warner Bid -- 2nd Update

12 янв. 2026 г., 18:20 UTC

Приобретения, слияния, поглощения

This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com

12 янв. 2026 г., 18:19 UTC

Обсуждения рынка

Modest Canadian Economic Impact Seen from Venezuela Changes -- Market Talk

12 янв. 2026 г., 18:16 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Comcast Could Unlock Value With a Spinoff of NBCUniversal Assets, Analysts Say -- Market Talk

12 янв. 2026 г., 18:09 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

12 янв. 2026 г., 18:09 UTC

Обсуждения рынка

Baidu's Outlook Bodes Well For Shares -- Market Talk

12 янв. 2026 г., 18:01 UTC

Приобретения, слияния, поглощения

QXO Is Raising Another $1.8 Billion for Its M&A War Chest -- Barrons.com

12 янв. 2026 г., 18:00 UTC

Обсуждения рынка

Canada's 'Breakeven' Employment Recalibrating -- Market Talk

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC ADR Прогноз

Целевая цена

By TipRanks

4.65% рост

Прогноз на 12 месяцев

Средняя 35.75 USD  4.65%

Максимум 37.5 USD

Минимум 34 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

2 ratings

0

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

26.64 / 28.37Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat